# An Investigator Initiated Study for OTOV101N+OTOV101C Injection

> **NCT05901480** · NA · UNKNOWN · sponsor: **Otovia Therapeutics** · enrollment: 25 (estimated)

## Conditions studied

- DFNB9

## Interventions

- **GENETIC:** OTOV101N+OTOV101C Injections

## Key facts

- **NCT ID:** NCT05901480
- **Lead sponsor:** Otovia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-26
- **Primary completion:** 2024-12-06
- **Final completion:** 2025-02-18
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05901480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05901480, "An Investigator Initiated Study for OTOV101N+OTOV101C Injection". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05901480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*